益丰药房：9月30日召开董事会会议

Group 1 - The company Yifeng Pharmacy held its 22nd meeting of the 5th board of directors on September 30, 2025, in Changsha, Hunan Province, to discuss various documents including the proposal regarding the second unlock conditions of the 2022 restricted stock incentive plan [1] - The meeting was conducted both in-person and via communication methods, indicating a hybrid approach to corporate governance [1] - The agenda included significant discussions on the stock incentive plan, which is crucial for employee motivation and retention [1] Group 2 - The announcement reflects the company's ongoing commitment to corporate governance and transparency in its operations [1] - The timing of the meeting and the topics discussed may influence investor sentiment and the company's stock performance in the near future [1] - The focus on the restricted stock incentive plan suggests a strategic move to align employee interests with shareholder value [1]